Revolution Medicines Inc (NASDAQ: RVMD) kicked off on Tuesday, up 1.58% from the previous trading day, before settling in for the closing price of $55.87. Over the past 52 weeks, RVMD has traded in a range of $18.79-$56.56.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 11.11%. While this was happening, its average annual earnings per share was recorded 12.24%. With a float of $139.21 million, this company’s outstanding shares have now reached $164.67 million.
Let’s determine the extent of company efficiency that accounts for 378 employees. In terms of profitability, gross margin is -18201.75%, operating margin of -80961.32%, and the pretax margin is -70448.92%.
Revolution Medicines Inc (RVMD) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Revolution Medicines Inc is 16.66%, while institutional ownership is 87.23%. The most recent insider transaction that took place on Nov 04 ’24, was worth 2,827,821. In this transaction an insider of this company sold 50,900 shares at a rate of $55.56, taking the stock ownership to the 300,170 shares. Before that another transaction happened on Nov 01 ’24, when Company’s insider sold 10,000 for $55.02, making the entire transaction worth $550,238. This insider now owns 20,424 shares in total.
Revolution Medicines Inc (RVMD) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 12.24% per share during the next fiscal year.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Take a look at Revolution Medicines Inc’s (RVMD) current performance indicators. Last quarter, stock had a quick ratio of 15.42. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12810.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.65, a number that is poised to hit -0.89 in the next quarter and is forecasted to reach -3.90 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Looking closely at Revolution Medicines Inc (NASDAQ: RVMD), its last 5-days average volume was 1.88 million, which is a jump from its year-to-date volume of 1.33 million. As of the previous 9 days, the stock’s Stochastic %D was 96.92%. Additionally, its Average True Range was 2.11.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 99.22%, which indicates a significant increase from 98.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.18% in the past 14 days, which was higher than the 41.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $46.54, while its 200-day Moving Average is $39.23. However, in the short run, Revolution Medicines Inc’s stock first resistance to watch stands at $57.45. Second resistance stands at $58.15. The third major resistance level sits at $59.39. If the price goes on to break the first support level at $55.51, it is likely to go to the next support level at $54.27. Should the price break the second support level, the third support level stands at $53.57.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
The company with the Market Capitalisation of 9.48 billion has total of 167,039K Shares Outstanding. Its annual sales at the moment are 11,580 K in contrast with the sum of -436,370 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -116,000 K.
